A Chinese broker reiterated that the CXO sector remains a core investment theme, supported by AIDD-driven demand, strong interim earnings with raised guidance, and recovering global biotech financing.
The broker maintains a bullish view on the China CXO sector, citing solid fundamentals and AIDD-related growth potential.
Free preview — more China A-share & HK research · About Us · Legal & Privacy